Sandhofer A, Iglseder B, Paulweber B, Ebenbichler C F, Patsch J R
Medical University Innsbruck, Austria.
Eur J Clin Invest. 2007 Feb;37(2):109-16. doi: 10.1111/j.1365-2362.2007.01751.x.
The International Diabetes Federation (IDF) published a new definition of the metabolic syndrome (MetS). For this definition we compared frequency, concordance, clinical and laboratory stigmata and carotid atherosclerosis with those of the established definitions by the National Cholesterol Education Program (NCEP) and World Health Organization (WHO).
A total of 1518 subjects (943 men, 575 women) from the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR), free of clinical atherosclerosis, were included in this study. To estimate insulin sensitivity two methods, i.e. homeostasis model assessment of insulin resistance (HOMA-IR) and the short insulin tolerance test, were employed. Carotid intima media thickness (IMT) and plaque extent were quantified for all subjects using high-resolution ultrasound.
Prevalence of the MetS was 18.7% for men and 16.2% for women for the WHO definition, 18.9% and 17.0%, respectively, for the NCEP definition, and 25.8% and 19.5%, respectively, for the IDF definition. Concordance was lower between the definitions of WHO and IDF (< 50%) than between NCEP and IDF (> 67%). Compared to subjects identified by NCEP definition, subjects identified in excess by IDF (3.1-11.7%) showed less insulin resistance and lower IMT and plaque extent indistinguishable from MetS-free subjects.
Our data suggest that the IDF definition includes subjects as MetS sufferers above these detected by NCEP or WHO, who exhibit considerably less insulin resistance and carotid atherosclerosis blurring the distinction between health and disease.
国际糖尿病联盟(IDF)发布了代谢综合征(MetS)的新定义。针对这一定义,我们将其与美国国家胆固醇教育计划(NCEP)和世界卫生组织(WHO)既定定义在发生率、一致性、临床和实验室特征以及颈动脉粥样硬化方面进行了比较。
本研究纳入了来自萨尔茨堡高个体风险人群动脉粥样硬化预防项目(SAPHIR)的1518名受试者(943名男性,575名女性),这些受试者均无临床动脉粥样硬化。为评估胰岛素敏感性,采用了两种方法,即胰岛素抵抗稳态模型评估(HOMA-IR)和短胰岛素耐量试验。使用高分辨率超声对所有受试者的颈动脉内膜中层厚度(IMT)和斑块范围进行了量化。
对于WHO定义,男性MetS患病率为18.7%,女性为16.2%;对于NCEP定义,分别为18.9%和17.0%;对于IDF定义,分别为25.8%和19.5%。WHO和IDF定义之间的一致性(<50%)低于NCEP和IDF之间的一致性(>67%)。与通过NCEP定义确定的受试者相比,IDF额外确定的受试者(3.1 - 11.7%)显示出较低的胰岛素抵抗、较低的IMT和斑块范围,与无MetS的受试者无明显差异。
我们的数据表明,IDF定义纳入的MetS患者比NCEP或WHO检测出的更多,这些患者表现出明显更低的胰岛素抵抗和颈动脉粥样硬化,模糊了健康与疾病之间的界限。